InvestorsHub Logo
Followers 105
Posts 16348
Boards Moderated 0
Alias Born 06/24/2014

Re: None

Tuesday, 02/06/2024 8:48:38 AM

Tuesday, February 06, 2024 8:48:38 AM

Post# of 8299
Tenax Therapeutics Announces USPTO Grants Notice of Allowance for U.S. Patent Application, Significantly Broadening IP Protection for Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TENX News